According to the latest study from Pure Global, Thailand's Medical Device and IVD Import Market: A Data-Driven Analysis of Market Size, Key Segments, and Competitive Dynamics (2021-2024), Thailand's market reveals an import-driven ecosystem with a total market value fluctuating between approximately $3.15 billion and $3.29 billion annually.

In 2024, the United States was the second-largest supplier with imports valued at $594 million (18.07 per cent market share), while Germany was third at $339 million (10.32 per cent market share). Greater China held the top spot by value at $639 million (19.43 per cent market share), but its position has been highly volatile, dropping from a 27.75 per cent share in 2022 to 18.55 per cent in 2023 before a partial recovery. South Korea's market share provides the clearest example of post-pandemic normalisation; after its import value surged by an incredible 287.6 per cent in 2021, it corrected sharply, falling by 51.8 per cent in 2022 as demand for its COVID-19 test kits evaporated.  

The "General & Plastic Surgery" category, heavily driven by aesthetics, was the largest and most dynamic segment, with import values growing from $624 million in 2021 to $883 million in 2024. This boom is fueled by Thailand's status as a top destination for cosmetic procedures, which attracts an estimated 60 per cent of its medical tourists.

The "Orthopaedic" sector also demonstrated strong, consistent growth, with imports rising from $150 million in 2021 to $233 million in 2024, directly reflecting the needs of an ageing population and medical tourists seeking joint replacements. Conversely, the "Clinical Chemistry" segment, which includes many pandemic-related diagnostics, saw its import value nearly halve from $856 million in 2022 to $462 million in 2024.